Chemoinformaics analysis of (2S,3S,6R)-6-(11-HYDROXYDODECYL)-2-METHYLPIPERIDIN-3-OL
| Molecular Weight | 299.499 | nRot | 11 |
| Heavy Atom Molecular Weight | 262.203 | nRig | 6 |
| Exact Molecular Weight | 299.282 | nRing | 1 |
| Solubility: LogS | -2.679 | nHRing | 1 |
| Solubility: LogP | 3.525 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 37 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 57.4353 |
| nHD | 3 | BPOL | 37.6887 |
| QED | 0.509 |
| Synth | 3.653 |
| Natural Product Likeliness | 2.17 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.734 |
| HIA | 0.226 |
| CACO-2 | -4.883 |
| MDCK | 0.0000327 |
| BBB | 0.079 |
| PPB | 0.743436 |
| VDSS | 1.226 |
| FU | 0.200789 |
| CYP1A2-inh | 0.194 |
| CYP1A2-sub | 0.795 |
| CYP2c19-inh | 0.232 |
| CYP2c19-sub | 0.139 |
| CYP2c9-inh | 0.058 |
| CYP2c9-sub | 0.542 |
| CYP2d6-inh | 0.8 |
| CYP2d6-sub | 0.859 |
| CYP3a4-inh | 0.046 |
| CYP3a4-sub | 0.132 |
| CL | 6.348 |
| T12 | 0.233 |
| hERG | 0.088 |
| Ames | 0.014 |
| ROA | 0.054 |
| SkinSen | 0.873 |
| Carcinogencity | 0.039 |
| EI | 0.015 |
| Respiratory | 0.927 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.583049 |